Protein biomarkers associated with acute renal failure and chronic kidney disease
暂无分享,去创建一个
A Lukas | A Kainz | B. Mayer | P. Perco | G. Mayer | A. Lukas | R. Oberbauer | A. Lukas | A. Kainz | R Oberbauer | P Perco | C Pleban | G Mayer | B Mayer | C. Pleban | Rainer Oberbauer | Gert Mayer
[1] K. Mori,et al. Iron, lipocalin, and kidney epithelia. , 2003, American journal of physiology. Renal physiology.
[2] F. Lai,et al. Messenger RNA expression of target genes in the urinary sediment of patients with chronic kidney diseases. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[3] R. Star,et al. Ischemic and nephrotoxic acute renal failure are distinguished by their broad transcriptomic responses. , 2006, Physiological genomics.
[4] W. Mauritz,et al. Serum S 100 B: A Marker of Brain Damage in Traumatic Brain Injury with and without Multiple Trauma , 2003, Shock.
[5] R. Jensen,et al. Global analysis of gene expression in renal ischemia-reperfusion in the mouse. , 2002, Biochemical and biophysical research communications.
[6] M. Nimtz,et al. Molecular characterization of beta-trace protein in human serum and urine: a potential diagnostic marker for renal diseases. , 1997, Glycobiology.
[7] A. S. Appel,et al. ACUTE RENAL FAILURE , 1967, Advances in Experimental Medicine and Biology.
[8] A. Desmoulière,et al. Interstitial alpha-smooth muscle actin: a prognostic marker in membranous nephropathy. , 1999, Clinical nephrology.
[9] A. Desmoulière,et al. Interstitial expression of alpha-SMA: an early marker of chronic renal allograft dysfunction. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[10] A. Bello,et al. Chronic kidney disease: the global challenge , 2005, The Lancet.
[11] A. Kribben,et al. Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. , 2004, Clinical chemistry.
[12] R. D. Marshall,et al. Excretion of Tamm-Horsfall glycoprotein in renal disease. , 1984, Clinical nephrology.
[13] T. Meyer,et al. Genome-wide gene-expression patterns of donor kidney biopsies distinguish primary allograft function , 2004, Laboratory Investigation.
[14] P. Devarajan,et al. Gene expression in early ischemic renal injury: clues towards pathogenesis, biomarker discovery, and novel therapeutics. , 2003, Molecular genetics and metabolism.
[15] L. King,et al. Keratinocyte-derived chemokine is an early biomarker of ischemic acute kidney injury. , 2006, American journal of physiology. Renal physiology.
[16] D. Fliser,et al. Increased resistin blood levels are not associated with insulin resistance in patients with renal disease. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[17] Shun-Fa Yang,et al. Relationships between circulating matrix metalloproteinase-2 and -9 and renal function in patients with chronic kidney disease. , 2006, Clinica chimica acta; international journal of clinical chemistry.
[18] Igor Jurisica,et al. Online Predicted Human Interaction Database , 2005, Bioinform..
[19] R. Safirstein. Acute renal failure: from renal physiology to the renal transcriptome. , 2004, Kidney international. Supplement.
[20] Anushya Muruganujan,et al. PANTHER: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification , 2003, Nucleic Acids Res..
[21] J. Ochieng,et al. Extracellular functions of galectin-3 , 2004, Glycoconjugate Journal.
[22] T. Meyer,et al. Alterations in Gene Expression in Cadaveric vs. Live Donor Kidneys Suggest Impaired Tubular Counterbalance of Oxidative Stress at Implantation , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[23] H. Nogami,et al. Up-regulation of galectin-3 in acute renal failure of the rat. , 2000, The American journal of pathology.
[24] S. Gullans,et al. Monitoring changes in gene expression in renal ischemia-reperfusion in the rat. , 2002, Kidney international.
[25] P. Ronco,et al. Do matrix metalloproteinases MMP-2 and MMP-9 (gelatinases) play a role in renal development, physiology and glomerular diseases? , 2001, Current opinion in nephrology and hypertension.
[26] Joseph V Bonventre,et al. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. , 2006, American journal of physiology. Renal physiology.
[27] Stephen M Hewitt,et al. Discovery of protein biomarkers for renal diseases. , 2004, Journal of the American Society of Nephrology : JASN.
[28] Timothy A Bertram,et al. Identification of putative gene based markers of renal toxicity. , 2004, Environmental health perspectives.
[29] M. Mitsnefes,et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. , 2003, Journal of the American Society of Nephrology : JASN.
[30] M S Pepe,et al. Phases of biomarker development for early detection of cancer. , 2001, Journal of the National Cancer Institute.
[31] A. Kribben,et al. Early detection of acute renal failure by serum cystatin C. , 2004, Kidney international.
[32] M. Yamanouchi,et al. Clinical evaluation of urinary excretion of liver-type fatty acid-binding protein as a marker for the monitoring of chronic kidney disease: a multicenter trial. , 2005, The Journal of laboratory and clinical medicine.
[33] R. Star,et al. Early detection of cysteine rich protein 61 (CYR61, CCN1) in urine following renal ischemic reperfusion injury. , 2002, Kidney international.
[34] Qing Ma,et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery , 2005, The Lancet.
[35] Youhua Liu,et al. Renal fibrosis: new insights into the pathogenesis and therapeutics. , 2006, Kidney international.
[36] J. Morrow,et al. Effect of Renal Transplantation on Biomarkers of Inflammation and Oxidative Stress in End-Stage Renal Disease Patients , 2005, Transplantation.
[37] Hiroaki Kitano,et al. The PANTHER database of protein families, subfamilies, functions and pathways , 2004, Nucleic Acids Res..
[38] R E Stoll,et al. Assessment of cisplatin-induced nephrotoxicity by microarray technology. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.
[39] T. Larson,et al. Glomerular filtration rate estimated by cystatin C among different clinical presentations. , 2006, Kidney international.
[40] Lynn Kl,et al. Excretion of Tamm-Horsfall glycoprotein in renal disease. , 1984 .
[41] F. Lönnqvist,et al. Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. , 2006, Kidney international.
[42] R. Poveda,et al. Goodpasture syndrome during the course of a Schönlein-Henoch purpura. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[43] H. Rabb,et al. Expression of SSAT, a novel biomarker of tubular cell damage, increases in kidney ischemia-reperfusion injury. , 2003, American journal of physiology. Renal physiology.
[44] K E Hammermeister,et al. Independent association between acute renal failure and mortality following cardiac surgery. , 1998, The American journal of medicine.
[45] M. Gladwin,et al. Biomarker and drug-target discovery using proteomics in a new rat model of sepsis-induced acute renal failure. , 2006, Kidney international.
[46] Changyu Shen,et al. Mining Alzheimer Disease Relevant Proteins from Integrated Protein Interactome Data , 2005, Pacific Symposium on Biocomputing.
[47] V. Thongboonkerd. Proteomic analysis of renal diseases: unraveling the pathophysiology and biomarker discovery , 2005, Expert review of proteomics.
[48] A. Lentsch,et al. Distinct and sequential upregulation of genes regulating cell growth and cell cycle progression during hepatic ischemia-reperfusion injury. , 2005, American journal of physiology. Cell physiology.
[49] A. Desmoulière,et al. Interstitial expression of α‐SMA: an early marker of chronic renal allograft dysfunction , 2002 .
[50] M. Yamanouchi,et al. Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease. , 2003, The Journal of laboratory and clinical medicine.
[51] H. Jüppner,et al. New PTH assays and renal osteodystrophy , 2004, Pediatric Nephrology.
[52] C. Gleason. Prostaglandins and the developing kidney. , 1987, Seminars in perinatology.
[53] S. Stepkowski,et al. Correlation between cyclosporine-induced nephrotoxicity in reduced nephron mass and expression of kidney injury molecule-1 and aquaporin-2 gene. , 2005, Transplantation proceedings.
[54] D. Powell,et al. Powell, D. W. et al. Myofibroblasts. I. Paracrine cells important in health and disease. Am. J. Physiol. 277, C1-C9 , 1999 .
[55] D. Lovett,et al. Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation. , 2003, The American journal of pathology.
[56] M. Pfeffer,et al. Biomarkers of inflammation and progression of chronic kidney disease. , 2005, Kidney international.
[57] L. Zimmerhackl. Evaluation of nephrotoxicity with renal antigens in children: Role of Tamm-Horsfall protein , 2005, European Journal of Clinical Pharmacology.
[58] W. Stetler-Stevenson,et al. Matrix metalloproteinases in renal development and disease. , 2000, Journal of the American Society of Nephrology : JASN.
[59] D R Flower,et al. Beyond the superfamily: the lipocalin receptors. , 2000, Biochimica et biophysica acta.
[60] J. Bonventre,et al. Kidney Injury Molecule-1 ( Kim-1 ) : A Tissue and Urinary Biomarker for Nephrotoxicant-Induced Renal Injury . , 2003 .
[61] J. Bonventre,et al. Towards the application of proteomics in renal disease diagnosis. , 2005, Clinical science.
[62] J. Bonventre,et al. Recent advances in the pathophysiology of ischemic acute renal failure. , 2003, Journal of the American Society of Nephrology : JASN.
[63] Christine A. White,et al. Estimating glomerular filtration rate in kidney transplantation: a comparison between serum creatinine and cystatin C-based methods. , 2005, Journal of the American Society of Nephrology : JASN.
[64] C. Brown,et al. Urinary and serum type III collagen: markers of renal fibrosis. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[65] R. Bellomo,et al. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group , 2004, Critical care.
[66] D. Powell. Water transport revisited , 1999, The Journal of physiology.
[67] Wei-Hwa Lee,et al. Calcium-binding proteins annexin A2 and S100A6 are sensors of tubular injury and recovery in acute renal failure. , 2005, Kidney international.
[68] J. Rhim,et al. Role of interleukin 10 and transforming growth factor beta1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[69] F. Scolari,et al. Uromodulin storage diseases: clinical aspects and mechanisms. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[70] R. Kucherlapati,et al. Differential gene expression following early renal ischemia/reperfusion. , 2003, Kidney international.
[71] John A Kellum,et al. Acute renal failure in critically ill patients: a multinational, multicenter study. , 2005, JAMA.
[72] D. Fliser,et al. Renal function in the elderly: impact of hypertension and cardiac function. , 1997, Kidney international.
[73] B. Molitoris,et al. Urinary actin, interleukin-6, and interleukin-8 may predict sustained ARF after ischemic injury in renal allografts. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[74] Kdoqi Disclaimer. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[75] G. Eknoyan,et al. National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification , 2003, Annals of Internal Medicine.
[76] V. Thongboonkerd. Proteomics in Nephrology: Current Status and Future Directions , 2004, American Journal of Nephrology.
[77] H. Redl,et al. Release of S100B Differs During Ischemia and Reperfusion of the Liver, the Gut, and the Kidney in Rats , 2004, Shock.
[78] D. Brigstock. The CCN family: a new stimulus package. , 2003, The Journal of endocrinology.
[79] W. Clarke. Proteomic Research in Renal Transplantation , 2006, Therapeutic drug monitoring.
[80] M. Kretzler,et al. Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analog. , 2003, Kidney international.
[81] D. Lovett,et al. Proteinases and glomerular matrix turnover. , 1992, Kidney international.